Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Guys the company is doing good. This is a long term stock, if you want instant satisfaction trade Tesla, or something like that.

The company is on track and there is still plenty of time to run. The company is even running 2 additional cohorts for phase 1b multi dose study. They are testing a higher level dose for phase 1 since there was no toxicity with 3 doses. They could go to 4 or 5 doses over 3 months and still have good safety, plus increased efficacy.

Also phase 2 trials are coming fast. Two of the phase 2 trials are starting Q4 2013, this year. The 3rd phase 2 trial is set for Q1 2014. Also here are the catalysts that I'm talking about from Life Sci advisors.

? 3Q 2013 – Two expansion cohorts to enroll in multi-dose Phase I trial for RXI-109.
? 4Q 2013 – RXI-109 Phase II trial in breast surgery scar revision patients.
? 4Q 2013 – RXI-109 Phase II trial initiation in abdominal scar revision patients.
? 1Q 2014 – RXI-109 Phase II trial for keloids expected to commence.
? 2H 2014 – Expected IND filing for RXI-109 for ophthalmological indications

Don't forget also that those phase 2 trials will update at months 6, and 9 so we will get reports of efficacy while the trials are running.